CASTELLI, FRANCESCO
 Distribuzione geografica
Continente #
AS - Asia 610
NA - Nord America 570
EU - Europa 404
SA - Sud America 182
AF - Africa 104
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 5
Totale 1.881
Nazione #
US - Stati Uniti d'America 504
SG - Singapore 253
BR - Brasile 130
HK - Hong Kong 113
CN - Cina 112
IT - Italia 105
DE - Germania 69
NL - Olanda 30
VN - Vietnam 27
FI - Finlandia 21
GB - Regno Unito 20
PL - Polonia 19
FR - Francia 18
CI - Costa d'Avorio 16
RU - Federazione Russa 14
ES - Italia 10
TR - Turchia 10
UY - Uruguay 10
CA - Canada 8
EC - Ecuador 8
IQ - Iraq 8
KR - Corea 8
AR - Argentina 7
PY - Paraguay 7
EE - Estonia 6
IN - India 6
MX - Messico 6
SE - Svezia 6
SK - Slovacchia (Repubblica Slovacca) 6
VE - Venezuela 6
AO - Angola 5
AT - Austria 5
DK - Danimarca 5
DZ - Algeria 5
HN - Honduras 5
IL - Israele 5
JP - Giappone 5
KE - Kenya 5
LA - Repubblica Popolare Democratica del Laos 5
LV - Lettonia 5
LY - Libia 5
ME - Montenegro 5
MK - Macedonia 5
NO - Norvegia 5
ZA - Sudafrica 5
AE - Emirati Arabi Uniti 4
AL - Albania 4
BF - Burkina Faso 4
BS - Bahamas 4
BW - Botswana 4
CL - Cile 4
CR - Costa Rica 4
CU - Cuba 4
GP - Guadalupe 4
GR - Grecia 4
IS - Islanda 4
JO - Giordania 4
MA - Marocco 4
MD - Moldavia 4
MY - Malesia 4
NG - Nigeria 4
SN - Senegal 4
TW - Taiwan 4
YE - Yemen 4
AD - Andorra 3
BB - Barbados 3
BE - Belgio 3
BG - Bulgaria 3
BZ - Belize 3
CZ - Repubblica Ceca 3
DJ - Gibuti 3
DO - Repubblica Dominicana 3
EG - Egitto 3
GE - Georgia 3
GF - Guiana Francese 3
GM - Gambi 3
GT - Guatemala 3
HT - Haiti 3
ID - Indonesia 3
IE - Irlanda 3
MG - Madagascar 3
NE - Niger 3
PA - Panama 3
PE - Perù 3
PT - Portogallo 3
RO - Romania 3
SI - Slovenia 3
TH - Thailandia 3
TJ - Tagikistan 3
XK - ???statistics.table.value.countryCode.XK??? 3
AF - Afghanistan, Repubblica islamica di 2
AU - Australia 2
BD - Bangladesh 2
BO - Bolivia 2
CH - Svizzera 2
CO - Colombia 2
CV - Capo Verde 2
CW - ???statistics.table.value.countryCode.CW??? 2
DM - Dominica 2
ET - Etiopia 2
Totale 1.812
Città #
Singapore 163
Hong Kong 112
Ashburn 109
Santa Clara 67
Munich 43
Beijing 38
Padova 34
Boardman 30
Los Angeles 24
Abidjan 16
Ann Arbor 16
Turku 15
Chandler 12
New York 12
São Paulo 12
Bytom 11
Buffalo 10
Montevideo 10
Hefei 9
Ho Chi Minh City 9
Rome 9
Nuremberg 8
Milan 7
Warsaw 7
Brooklyn 6
Istanbul 6
Rio de Janeiro 6
Seoul 6
Baghdad 5
Chicago 5
Durham 5
Hanoi 5
Luanda 5
Portomaggiore 5
Riga 5
Skopje 5
Terrassa Padovana 5
Venice 5
Vientiane 5
Amman 4
Cambridge 4
Dakar 4
Dallas 4
Havana 4
Hounslow 4
Nairobi 4
Nassau 4
Podgorica 4
Quito 4
Redondo Beach 4
Salvador 4
San Francisco 4
Stezzano 4
Tokyo 4
Andorra la Vella 3
Antananarivo 3
Asunción 3
Bangkok 3
Banjul 3
Bridgetown 3
Cayenne 3
Chisinau 3
Columbus 3
Des Moines 3
Dubai 3
Dushanbe 3
Fairfield 3
Frankfurt am Main 3
Gaborone 3
Helsinki 3
Johannesburg 3
Lainate 3
London 3
Medford 3
Newcastle 3
Ogden 3
Oslo 3
Ouagadougou 3
Panama City 3
Paris 3
Port-au-Prince 3
Princeton 3
Reykjavik 3
San Giorgio delle Pertiche 3
San José 3
Santo Domingo Este 3
Seattle 3
Secaucus 3
Stockholm 3
Tallinn 3
Tel Aviv 3
Tirana 3
Vicenza 3
Aden 2
Ambato 2
Ankara 2
Annapolis 2
Barquisimeto 2
Basse-Terre 2
Bishkek 2
Totale 1.053
Nome #
Determinants of virologic and immunologic outcomes in chronically HIV-infected subjects undergoing repeated treatment interruptions: The Istituto Superiore di Sanità-Pulsed Antiretroviral Therapy (ISS-PART) study 113
Human immunodeficiency virus continuum of care in 11 european union countries at the end of 2016 overall and by key population: Have we made progress? 100
FLEXICOIL: Flexible Robotized Coils Winding for Electric Machines Manufacturing Industry 91
Development of a definition for Rapid Progression (RP) of renal function in HIV-positive persons: The D:A:D study 88
Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials 84
The impact of DAA-mediated HCV eradication on CD4+ and CD8+ T lymphocyte trajectories in HIV/HCV coinfected patients: Data from the ICONA Foundation Cohort 84
Evaluation of HIV transmission clusters among natives and foreigners living in Italy 82
Italian recommendations for influenza and pneumococcal vaccination in adult patients with autoimmune rheumatic diseases 72
Automated and Flexible Coil Winding Robotic Framework 70
Exposure to abacavir and biomarkers of cardiovascular disease in HIV-1-infected patients on suppressive antiretroviral therapy: A longitudinal study 69
Italian recommendations for influenza and pneumococcal vaccination in adult patients with autoimmune rheumatic diseases 69
Elderly HIV-positive women: A gender-based analysis from the Multicenter Italian “GEPPO” Cohort 69
CD4/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: An observational cohort study 68
Switching to dual/monotherapy determines an increase in CD8+ in HIV-infected individuals: An observational cohort study 68
Virological response and retention in care according to time of starting ART in Italy: Data from the Icona Foundation Study cohort 67
Teaching door assembly tasks in uncertain environment 67
Effectiveness of dolutegravir-based regimens as either first-line or switch antiretroviral therapy: data from the Icona cohort 66
Long-term efficacy of dolutegravir in treatment-experienced subjects failing therapy with HIV-1 integrase strand inhibitor-resistant virus 66
Risk factors and occurrence of rash in HIV-positive patients not receiving nonnucleoside reverse transcriptase inhibitor: Data from a randomized study evaluating use of protease inhibitors in nucleoside-experienced patients with very low CD4 levels (<50 cells/μL) 65
Cytomegalovirus coinfection is associated with an increased risk of severe non-AIDS-defining events in a large cohort of HIV-infected patients 64
Pre-ART HIV-1 DNA in CD4+ T cells correlates with baseline VIRO-immunological status and outcome in patients under first-line ART 63
Durability of Integrase STrand Inhibitor (InSTI)-based regimen in geriatric people living with HIV in the GEPPO cohort 59
Antiretroviral therapy in geriatric HIV patients: The GEPPO cohort study 58
Longitudinal analysis of HIV-1 coreceptor tropism by single and triplicate HIV-1 RNA and DNA sequencing in patients undergoing successful first-line antiretroviral therapy 54
Effectiveness of Switching to Darunavir/Cobicistat in Virologically Suppressed HIV-Positive Patients Receiving Ritonavir-Boosted Protease Inhibitor-Based Regimen: The "STORE" Study 51
TB meningitis in HIV-positive patients in Europe and Argentina: Clinical dutcome and factors associated with mortality 51
Evolution of HIV-1 tropism at quasispecies level after 5 years of combination antiretroviral therapy in patients always suppressed or experiencing episodes of virological failure 43
null 9
Totale 1.910
Categoria #
all - tutte 9.365
article - articoli 8.542
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.907


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202110 0 0 2 0 0 0 1 3 1 0 2 1
2021/202221 1 7 0 1 1 0 1 0 1 0 0 9
2022/202325 3 0 0 3 8 1 0 4 3 0 3 0
2023/2024234 0 63 20 19 17 24 31 7 11 5 19 18
2024/2025872 4 126 24 27 89 16 54 83 74 34 149 192
2025/2026719 200 201 318 0 0 0 0 0 0 0 0 0
Totale 1.910